KP104

KP104 · Kira Pharmaceuticals (US), LLC.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for KP104, covering 2024-10-28 to 2024-10-28. Get the full timeline:

Most recent: Clinical Trial Update: To Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of KP104 [Phase 2]